Elevated circulating BACE2 captures chronic glycemic burden and enhances the clinical identification of type 2 diabetes
Bo Li, Zhixing Luo, Zhongyu Chen, Han Wang, Shiqiao Zhao · 2026
Read Elevated circulating BACE2 captures chronic glycemic burden and enhances the clinical identification of type 2 diabetes by Bo Li, Zhixing Luo, Zhongyu Chen, Han Wang, Shiqiao Zhao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13217922.txt.
Description
Bo Li, Zhixing Luo, Zhongyu Chen, Han Wang, and Shiqiao Zhao test a blood protein as a diabetes signal in a 2026 study. BACE2 is an enzyme known from brain research that also works in the insulin-making cells of the pancreas. The team measured it in blood from 161 people with type 2 diabetes and 134 with normal glucose control. Levels ran clearly higher in the diabetes group, and the top quarter of levels carried over seven times the adjusted odds of disease.
The protein tracked insulin resistance and poor blood fats, with long-term blood sugar the strongest driver of its level. Paired with a standard resistance index, it identified diabetes far better than alone. A dynamic marker of sugar burden could sharpen screening.
Catalog record
| CREATOR | Bo Li, Zhixing Luo, Zhongyu Chen, Han Wang, Shiqiao Zhao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |